Vanguard Personalized Indexing Management
ATYR

Vanguard Personalized Indexing Management’s aTyr Pharma ATYR Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.89K Sell
14,899
-1,770
-11% -$1.16K ﹤0.01% 2232
2026
Q1 		$13K Buy
+16,669
New +$14.1K ﹤0.01% 2143

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Personalized Indexing Management's ATYR Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its aTyr Pharma (ATYR) stake by 11% in Q2 2026, selling an estimated $1.16K and leaving 14,899 shares worth $8.89K. The position accounts for ﹤0.01% of the portfolio, ranked #2232.

Vanguard Personalized Indexing Management first reported a position in ATYR in Q1 2026 and has held it in 2 quarters since. The position peaked at $13K in Q1 2026. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Vanguard Personalized Indexing Management held 14,899 shares of aTyr Pharma worth $8.89K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 1,770 aTyr Pharma shares in Q2 2026, an estimated $1.16K.
  • aTyr Pharma made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2232 holding.
  • Vanguard Personalized Indexing Management first reported a position in aTyr Pharma in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Personalized Indexing Management's aTyr Pharma position peaked at $13K in Q1 2026.
  • 90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.